Investment analysts at William Blair increased their Q2 2025 earnings per share estimates for Amplitude in a research note issued on Tuesday, March 11th. William Blair analyst A. Bhatia now ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Amplitude (NASDAQ:AMPL – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They currently have a $16.

We recently published a list of 10 Best Performing Software Stocks to Buy According to Analysts. In this article, we are ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

PAI Partners has entered exclusive talks to sell majority stake in Amplitude Surgical, a European medical technology business, alongside the company’s management team and two minority shareholders.

Meeting to be held in Boston on March 13 hosted by KeyBanc.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based ...

RBC Capital analyst Gordon Ramsay upgraded Amplitude Energy (COPJF) to Outperform from Sector Perform with a price target of A$0.28, up from ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...